Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap)
Recruiting · NCT06626386 · Observational (researchers observe without assigning treatment) · Lead sponsor: Heinrich-Heine University, Duesseldorf
View the official record on ClinicalTrials.gov →Interventions studied
PSA testing
What this trial is about
The aim of the PSA-Cap study is to test the comparability of measurements of total PSA in serum from venipuncture and in serum from capillary blood using anonymized diagnostic blood samples from patients. Furthermore, a stability test of the samples is carried out after storage at room temperature for 24, 72/96 and 168 hours. Particular attention is paid to the comparability of the measurement results and the influence of the transportation time.
Who can take part
Age range
45 Years to 70 Years
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Men aged from 45 to 70 years
- Informed consent for PSA measurement for prostate cancer screening
Exclusion criteria
- Patients unable to give consent
Where it is running
1 location listed.
- Klinik für Urologie, Universitätsklinikum Düsseldorf - Düsseldorf, North Rhine-Westphalia, Germany